CD8A and neoplasm: After combined MWA and Flt3L treatment, a substantial increase in the proportion of tumor‐specific CD8+ T cells (CD8+TCRVα2+TCRVβ5+) in the TdLN relative to those in the other groups was observed (Figure 4B,E).